Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02010190 · ClinicalTrials.gov registry record
Vascular Assessment in Adult Survivors of Childhood Cancer
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 394
- Enrollment target
NCT02010190 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 394 participants.
The verdict
NCT02010190 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 394 participants
- Enrollment target
Study Summary
This is an observational study that will collect data from adult survivors of childhood cancer and compare it to data collected from age- and gender-matched controls for the purpose of assessing vascular risk among cancer survivors. Advances in cancer therapies have led to increasing numbers of adults previously treated for a pediatric malignancy, many of whom experience late adverse health-related sequelae and are at risk for developing chronic conditions related to their prior therapy. The epidemiology of many end-organ toxicities has been described, yet the pathophysiologic mechanisms of injury are incompletely understood. One mechanism may be damage to the circulatory system, in particular the endothelial layer, initiating an inflammatory state leading to dysfunction and premature atherosclerotic disease. This process may begin and significantly progress in a sub-clinical nature for many years prior to manifesting as a cardio- or cerebrovascular event. Using established and novel biomarkers predictive of atherosclerotic disease combined with unique measurements of vascular function, this study will assess pre-clinical vascular disease in a population of childhood and adolescent cancer survivors. The goals of this project are to investigate the effects of cancer therapy on the vascular system and acquire new knowledge with which to risk-stratify survivors and plan interventional studies to prevent or reduce premature vascular morbidity and mortality.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02010190
The ClinicalTrials.gov registry entry for NCT02010190 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 394 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02010190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02010190 about?
NCT02010190 is a clinical study titled "Vascular Assessment in Adult Survivors of Childhood Cancer". This is an observational study that will collect data from adult survivors of childhood cancer and compare it to data collected from age- and gender-matched controls for the purpose of assessing vascular risk among cancer survivors. Advances in cancer therapies have led to increasing numbers of adu...
What is the current status of trial NCT02010190?
This trial is currently completed. The enrollment target is 394 participants. The study started on 2013-12. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT02010190?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.